申请人:Boehringer Ingelheim GmbH
公开号:US04213984A1
公开(公告)日:1980-07-22
Compounds of the formula ##STR1## wherein R.sub.1 is alkyl of 3 to 12 carbon atoms; unsaturated aliphatic hydrocarbyl of 3 to 20 carbon atoms comprising 1 to 3 double bonds and/or one triple bond; phenyl(alkyl of 2 to 4 carbon atoms); methylenedioxybenzyl; chlorobenzyl; indan-5-ylmethyl; indan-3-ylmethyl; phenyl(alkenyl of 2 to 4 carbon atoms); cycloalkyl of 5 to 7 carbon atoms; (cycloalkyl of 3 to 10 carbon atoms)methyl; (methylcycloalkyl of 4 to 11 carbon atoms)methyl; morpholino(alkyl of 2 to 3 carbon atoms); pyrrolidino(alkyl of 2 to 3 carbon atoms); piperidino (alkyl of 2 to 3 carbon atoms); 4-methylpiperazino(alkyl of 2 to 3 carbon atoms); or, when R.sub.3 and/or R.sub.4 are methyl or ethyl, also methyl or ethyl; R.sub.2 is hydrogen, methyl or ethyl; and R.sub.3 and R.sub.4 are each hydrogen, methyl or ethyl; and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as the salts are useful as anti-ulcerogenics and secretion inhibitors.
式为##STR1##的化合物,其中R.sub.1是3到12个碳原子的烷基;不饱和脂肪烃基,碳原子数为3到20,包括1到3个双键和/或一个三键;苯基(2到4个碳原子的烷基);亚甲二氧基苯甲基;氯苯甲基;茚-5-基甲基;茚-3-基甲基;苯基(2到4个碳原子的烯基);5到7个碳原子的环烷基;(3到10个碳原子的环烷基)甲基;(4到11个碳原子的甲基环烷基)甲基;吗啉(2到3个碳原子的烷基);吡咯啉(2到3个碳原子的烷基);哌啶(2到3个碳原子的烷基);4-甲基哌嗪(2到3个碳原子的烷基);或者,当R.sub.3和/或R.sub.4是甲基或乙基时,也可以是甲基或乙基;R.sub.2是氢、甲基或乙基;R.sub.3和R.sub.4分别是氢、甲基或乙基;以及其非毒性、药理学上可接受的酸盐。这些化合物以及盐可用作抗溃疡剂和分泌抑制剂。